Skip to content

Scotts Miracle-Gro SMG Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

3M logo
3MMMM
$3.73B-41.1%

Other financials

Income statement

See full
Revenue$1.5B+5.0%
Gross profit$610.5M+11.5%
Operating income$401.8M+14.9%
Net income$238.6M+9.7%
EPS (diluted)$4.04+8.6%

Balance sheet

See full
Cash & equivalents$6.2M-28.7%
Total debt$2.7B-5.5%
Total equity-$286.5M+1.2%
Total assets$3.4B-3.5%

Cash flow

See full
Operating cash flow-$370.4M+16.8%
CapEx$18.6M+124%
Free cash flow-$390.4M+17.7%

Valuation

See full
Market cap$3.69B+11.9%

Profitability

See full
Gross margin32.7%+3.4pp
Operating margin0.3%-0.2pp
Net margin1.6%+0.9pp
FCF margin10.8%-3.2pp

Returns & leverage

See full
Return on equity-47.6%+104pp
Debt / equity25.2×+16.1×
Current ratio1.3×-0.4×

Where this comes from

Reported directly by Scotts Miracle-Gro in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Scotts Miracle-Gro’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scotts Miracle-Gro's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scotts Miracle-Gro's cash and cash equivalents, end of period?
Scotts Miracle-Gro (SMG) reported cash and cash equivalents, end of period of $6.2M in Q1 2026.
How has Scotts Miracle-Gro's cash and cash equivalents, end of period changed year-over-year?
Scotts Miracle-Gro's cash and cash equivalents, end of period decreased by 28.7% year-over-year, from $8.7M to $6.2M.
What is the long-term trend for Scotts Miracle-Gro's cash and cash equivalents, end of period?
Over 5 years (2020 to 2025), Scotts Miracle-Gro's cash and cash equivalents, end of period has grown at a 14.6% compound annual growth rate (CAGR), from $16.6M to $32.8M.